The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Dendreon; Janssen-Cilag
Speakers' Bureau - Astellas Pharma; Bavarian Nordic; Bayer; Bristol-Myers Squibb; Janssen-Cilag
Development and validation of a bioanalytical assay on LC/MS/MS to quantify enzalutamide and N-desmethylenzalutamide in human plasma.
 
Mette Benoist
Travel, Accommodations, Expenses - Astellas Pharma
 
Eric van der Meulen
No Relationships to Disclose
 
Inge Van Oort
Consulting or Advisory Role - Astellas Pharma (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Speakers' Bureau - GlaxoSmithKline
 
Jack Schalken
Employment - noviogendix
Leadership - noviogendix
Stock and Other Ownership Interests - noviogendix
Honoraria - Astellas Pharma; Noviogendix
Consulting or Advisory Role - Hologic
Speakers' Bureau - Astellas Pharma
Patents, Royalties, Other Intellectual Property - Noviogendix; Radboud University Medical Centre
Expert Testimony - Mylan
 
Winald Gerritsen
No Relationships to Disclose
 
David Burger
Consulting or Advisory Role - MSD (Inst); ViiV Healthcare (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Janssen-Cilag (Inst); MSD (Inst); ViiV Healthcare (Inst)
Travel, Accommodations, Expenses - MSD
 
Nielka P van Erp
Research Funding - Astellas Pharma (Inst); Janssen-Cilag (Inst); Novartis (Inst)